These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20406201)

  • 1. A novel CC chemokine receptor 4 antagonist RS-1269 inhibits ovalbumin-induced ear swelling and lipopolysaccharide-induced endotoxic shock in mice.
    Nakagami Y; Kawashima K; Etori M; Yonekubo K; Suzuki C; Jojima T; Kuribayashi T; Nara F; Yamashita M
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):793-7. PubMed ID: 20406201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.
    Nakagami Y; Kawashima K; Yonekubo K; Etori M; Jojima T; Miyazaki S; Sawamura R; Hirahara K; Nara F; Yamashita M
    Eur J Pharmacol; 2009 Dec; 624(1-3):38-44. PubMed ID: 19818758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligand- and antigen-induced mouse models.
    Komiya T; Sugiyama T; Takeda K; Watanabe N; Imai M; Kokubo M; Tokuda N; Ochiai H; Habashita H; Shibayama S
    Eur J Pharmacol; 2013 Nov; 720(1-3):335-43. PubMed ID: 24140571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation.
    Sato T; Komai M; Iwase M; Kobayashi K; Tahara H; Ohshima E; Arai H; Miki I
    Pharmacology; 2009; 84(3):171-82. PubMed ID: 19713720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.
    Yoneyama H; Harada A; Imai T; Baba M; Yoshie O; Zhang Y; Higashi H; Murai M; Asakura H; Matsushima K
    J Clin Invest; 1998 Dec; 102(11):1933-41. PubMed ID: 9835618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs.
    Nakagami Y; Kawase Y; Yonekubo K; Nosaka E; Etori M; Takahashi S; Takagi N; Fukuda T; Kuribayashi T; Nara F; Yamashita M
    Biol Pharm Bull; 2010; 33(6):1067-9. PubMed ID: 20522980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock.
    Chvatchko Y; Hoogewerf AJ; Meyer A; Alouani S; Juillard P; Buser R; Conquet F; Proudfoot AE; Wells TN; Power CA
    J Exp Med; 2000 May; 191(10):1755-64. PubMed ID: 10811868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
    Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
    Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
    Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4.
    Wang Y; Zhang Y; Han W; Li D; Tian L; Yin C; Ma D
    Int J Biochem Cell Biol; 2008; 40(5):909-19. PubMed ID: 18069042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
    Juremalm M; Olsson N; Nilsson G
    Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.
    Andrew DP; Chang MS; McNinch J; Wathen ST; Rihanek M; Tseng J; Spellberg JP; Elias CG
    J Immunol; 1998 Nov; 161(9):5027-38. PubMed ID: 9794440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.
    Sebastiani S; Danelon G; Gerber B; Uguccioni M
    Eur J Immunol; 2005 Mar; 35(3):746-56. PubMed ID: 15714581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.
    Matsuo K; Nagakubo D; Komori Y; Fujisato S; Takeda N; Kitamatsu M; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Yoshie O; Nakayama T
    J Invest Dermatol; 2018 Aug; 138(8):1764-1773. PubMed ID: 29510192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.
    Alexandre-Moreira MS; Takiya CM; de Arruda LB; Pascarelli B; Gomes RN; Castro Faria Neto HC; Lima LM; Barreiro EJ
    Int Immunopharmacol; 2005 Mar; 5(3):485-94. PubMed ID: 15683845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.